| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Annamaria Colao, Renata S Auriemma, Mariano Galdiero, Paolo Cappabianca, Luigi M Cavallo, Felice Esposito, Ludovica F S Grasso, Gaetano Lombardi, Rosario Pivonell. Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. The Journal of clinical endocrinology and metabolism. vol 94. issue 2. 2009-03-30. PMID:19001517. |
the aim of the study was to investigate the 5-yr impact of surgery and somatostatin analogs (ssa) on glucose metabolism in acromegaly. |
2009-03-30 |
2023-08-12 |
Not clear |
| Iñaki F Trocóniz, Josep-María Cendrós, Concepción Peraire, Joaquim Ramis, Maria J Garrido, Paolo F Boscani, Rosendo Obac. Population pharmacokinetic analysis of lanreotide Autogel in healthy subjects : evidence for injection interval of up to 2 months. Clinical pharmacokinetics. vol 48. issue 1. 2009-03-24. PMID:19071884. |
lanreotide is a somatostatin analogue used for the treatment of acromegaly and neuroendocrine tumours. |
2009-03-24 |
2023-08-12 |
human |
| R Attanasio, A Mainolfi, F Grimaldi, R Cozzi, M Montini, C Carzaniga, S Grottoli, L Cortesi, M Albizzi, R M Testa, L Fatti, D De Giorgio, C Scaroni, F Cavagnini, P Loli, G Pagani, E Ghig. Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients. Journal of endocrinological investigation. vol 31. issue 8. 2009-02-06. PMID:18852531. |
development of gallstones (gs) is reported during the use of somatostatin analogs (sa) that are at present the mainstay for the medical treatment of acromegaly. |
2009-02-06 |
2023-08-12 |
Not clear |
| Leda R Cavalin, Maria L de Oliveira, Leandro A Dieh. Octreotide-LAR-associated erythema multiforme in an acromegalic subject: case report. Arquivos brasileiros de endocrinologia e metabologia. vol 52. issue 1. 2009-01-26. PMID:18345409. |
long-acting somatostatin analogs are often used for treating acromegaly, either as adjuvant to surgery or radiotherapy or, more recently, as a primary therapeutic option. |
2009-01-26 |
2023-08-12 |
human |
| S Petersenn, M Buchfelder, M Reincke, C M Strasburger, H Franz, R Lohmann, H-J Quabbe, U Plöckinge. Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register. European journal of endocrinology. vol 159. issue 5. 2008-11-24. PMID:18755874. |
results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the german acromegaly register. |
2008-11-24 |
2023-08-12 |
Not clear |
| S Petersenn, M Buchfelder, M Reincke, C M Strasburger, H Franz, R Lohmann, H-J Quabbe, U Plöckinge. Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register. European journal of endocrinology. vol 159. issue 5. 2008-11-24. PMID:18755874. |
we retrospectively analyzed the data on surgery, primary somatostatin analog (ssa) therapy, surgery preceded by ssa, and ssa preceded by surgery in 1485 patients from the german acromegaly register. |
2008-11-24 |
2023-08-12 |
Not clear |
| Aleksandra Jawiarczyk, Marcin Kałuzny, Marek Bolanowski, Grazyna Bednarek-Tupikowsk. Additional metabolic effects of adding GH receptor antagonist to long-acting somatostatin analog in patients with active acromegaly. Neuro endocrinology letters. vol 29. issue 4. 2008-11-12. PMID:18766168. |
additional metabolic effects of adding gh receptor antagonist to long-acting somatostatin analog in patients with active acromegaly. |
2008-11-12 |
2023-08-12 |
Not clear |
| Aleksandra Jawiarczyk, Marcin Kałuzny, Marek Bolanowski, Grazyna Bednarek-Tupikowsk. Additional metabolic effects of adding GH receptor antagonist to long-acting somatostatin analog in patients with active acromegaly. Neuro endocrinology letters. vol 29. issue 4. 2008-11-12. PMID:18766168. |
somatostatin analogs, dopamine agonists and gh-receptor antagonist--pegvisomant are used in medical therapy of acromegaly. |
2008-11-12 |
2023-08-12 |
Not clear |
| Agatha A van der Klaauw, Alberto M Pereira, Klaas W van Kralingen, Klaus F Rabe, Johannes A Romij. Somatostatin analog treatment is associated with an increased sleep latency in patients with long-term biochemical remission of acromegaly. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 18. issue 5. 2008-10-31. PMID:18502671. |
somatostatin analog treatment is associated with an increased sleep latency in patients with long-term biochemical remission of acromegaly. |
2008-10-31 |
2023-08-12 |
Not clear |
| Agatha A van der Klaauw, Alberto M Pereira, Klaas W van Kralingen, Klaus F Rabe, Johannes A Romij. Somatostatin analog treatment is associated with an increased sleep latency in patients with long-term biochemical remission of acromegaly. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 18. issue 5. 2008-10-31. PMID:18502671. |
presently, it is unknown whether somatostatin analog treatment affects sleep parameters in patients with acromegaly. |
2008-10-31 |
2023-08-12 |
Not clear |
| Sophie Vallette, Omar Serr. Octreotide LAR for the treatment of acromegaly. Expert opinion on drug metabolism & toxicology. vol 4. issue 6. 2008-10-30. PMID:18611118. |
somatostatin analogs previously considered as adjuvant therapy in acromegaly are increasingly used as a first-line therapy in selected cases. |
2008-10-30 |
2023-08-12 |
Not clear |
| b' M \\xc5\\x98ez\\xc3\\xa1\\xc4\\x8dov\\xc3\\xa1, J \\xc4\\x8c\\xc3\\xa1p, D Vokurkov\\xc3\\xa1, E Luk\\xc3\\xa1\\xc5\\xa1ov\\xc3\\xa1, J V\\xc3\\xa1vrov\\xc3\\xa1, J Cerman, V Ma\\xc5\\xa1\\xc3\\xadn, N Maz\\xc3\\xa1nkov\\xc3\\xa. Effect of somatostatin on repair of ionizing radiation-induced DNA damage in pituitary adenoma cells GH3. Physiological research. vol 57. issue 2. 2008-09-17. PMID:17552875.' |
ionizing radiation and somatostatin analogues are used for acromegaly treatment to achieve normalization or reduction of growth hormone hypersecretion and tumor shrinkage. |
2008-09-17 |
2023-08-12 |
Not clear |
| Robert D Murray, Shlomo Melme. A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. The Journal of clinical endocrinology and metabolism. vol 93. issue 8. 2008-09-08. PMID:18477663. |
a critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly. |
2008-09-08 |
2023-08-12 |
Not clear |
| Albert Becker. Does preoperative somatostatin analog treatment improve surgical cure rates in acromegaly? A new look at an old question. The Journal of clinical endocrinology and metabolism. vol 93. issue 8. 2008-09-08. PMID:18685119. |
does preoperative somatostatin analog treatment improve surgical cure rates in acromegaly? |
2008-09-08 |
2023-08-12 |
Not clear |
| Annamaria Colao, Rosario Pivonello, Maurizio Galderisi, Paolo Cappabianca, Renata S Auriemma, Mariano Galdiero, Luigi M Cavallo, Felice Esposito, Gaetano Lombard. Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy. The Journal of clinical endocrinology and metabolism. vol 93. issue 7. 2008-08-21. PMID:18445662. |
impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy. |
2008-08-21 |
2023-08-12 |
Not clear |
| Annamaria Colao, Josef Marek, Miklos I Goth, Philippe Caron, Jean Marc Kuhn, Francesco M Minuto, Neil J Weissma. No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly. The Journal of clinical endocrinology and metabolism. vol 93. issue 6. 2008-07-17. PMID:18381583. |
no greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly. |
2008-07-17 |
2023-08-12 |
Not clear |
| Israel Hodish, Ariel Barka. Long-term effects of pegvisomant in patients with acromegaly. Nature clinical practice. Endocrinology & metabolism. vol 4. issue 6. 2008-07-01. PMID:18431372. |
despite improved surgical and radiotherapy techniques and the development of long-acting somatostatin analogs, some patients with acromegaly cannot attain biochemical remission. |
2008-07-01 |
2023-08-12 |
Not clear |
| Cristina L Ronchi, Erica Rizzo, Andrea G Lania, Rosario Pivonello, Silvia Grottoli, Annamaria Colao, Ezio Ghigo, Anna Spada, Maura Arosio, Paolo Beck-Pecco. Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal. European journal of endocrinology. vol 158. issue 1. 2008-06-10. PMID:18166813. |
preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal. |
2008-06-10 |
2023-08-12 |
Not clear |
| Stine Lyngvi Fougner, Jens Bollerslev, Fahim Latif, John K Hald, Terje Lund, Jon Ramm-Pettersen, Jens Petter Ber. Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment. The Journal of clinical endocrinology and metabolism. vol 93. issue 4. 2008-05-27. PMID:18230656. |
medical treatment of acromegaly with somatostatin analogs (smss), like octreotide, is well established, but the clinical effect is variable. |
2008-05-27 |
2023-08-12 |
Not clear |
| Miles J Levy, Manjit Matharu, Peter J Goadsb. Chronic headache and pituitary tumors. Current pain and headache reports. vol 12. issue 1. 2008-05-27. PMID:18417028. |
somatostatin analogues may be highly effective at aborting headache associated with functionally active pituitary lesions, particularly in the case of acromegaly. |
2008-05-27 |
2023-08-12 |
Not clear |